share_log

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

中進醫療 | 6-K:外國發行人報告

美股SEC公告 ·  02/02 05:14

Moomoo AI 已提取核心訊息

Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info...Show More
Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info-Tech Co., Ltd. Ms. Guo has earned a master's degree in accounting and a bachelor's degree in management and accounting, and holds a CPA Certificate in China. Her appointment satisfies the 'independence' requirements of the Nasdaq listing rule and Rule 10A-3 under the Securities Exchange Act. The formal announcement of her appointment was signed by Erqi Wang on behalf of Jin Medical International Ltd. on February 1, 2024.
外國私人發行人金醫療國際有限公司報告說,郭豔如被任命爲董事會獨立成員以及審計委員會、薪酬委員會及提名和公司治理委員會主席。該任命由董事會於 2024 年 1 月 26 日作出,並於 2024 年 1 月 30 日生效。郭女士自2014年3月起在納斯達克上市公司Shineco, Inc. 擔任首席會計師,爲該職位帶來了豐富的經驗。她的背景包括對美國公認會計原則、國際財務報告準則和CAS的廣泛了解,以及在納斯達克上市公司擁有十多年的會計經驗。在擔任現任職務之前,她曾在北京移動互動有限公司任職。Ltd. 和北京盈科信息技術有限公司。郭女士擁有會計學碩士學位和管理與會計學士學位,並持有中國註冊會計師證書。她的任命符合納斯達克上市規則和《證券交易法》第10A-3條的 “獨立性” 要求。她的正式任命公告由王爾奇代表金醫療國際有限公司於2024年2月1日簽署。
外國私人發行人金醫療國際有限公司報告說,郭豔如被任命爲董事會獨立成員以及審計委員會、薪酬委員會及提名和公司治理委員會主席。該任命由董事會於 2024 年 1 月 26 日作出,並於 2024 年 1 月 30 日生效。郭女士自2014年3月起在納斯達克上市公司Shineco, Inc. 擔任首席會計師,爲該職位帶來了豐富的經驗。她的背景包括對美國公認會計原則、國際財務報告準則和CAS的廣泛了解,以及在納斯達克上市公司擁有十多年的會計經驗。在擔任現任職務之前,她曾在北京移動互動有限公司任職。Ltd. 和北京盈科信息技術有限公司。郭女士擁有會計學碩士學位和管理與會計學士學位,並持有中國註冊會計師證書。她的任命符合納斯達克上市規則和《證券交易法》第10A-3條的 “獨立性” 要求。她的正式任命公告由王爾奇代表金醫療國際有限公司於2024年2月1日簽署。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息